Baynes Roy D.

CIK 00016807395 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001680739

Recent Transactions

50 trades

Exercise/Conversion
Natera, Inc.$NTRA
Stock Option (right to buy)
2025-11-20−600→ 0 total
Sale
Natera, Inc.$NTRA
Common Stock
2025-11-20$221.81/sh−900→ 23,943 total
Sale
Natera, Inc.$NTRA
Common Stock
2025-11-20$222.90/sh−1,800→ 22,143 total
Exercise/Conversion
Natera, Inc.$NTRA
Stock Option (right to buy)
2025-11-20−7,068→ 0 total
Sale
Natera, Inc.$NTRA
Common Stock
2025-11-20$223.90/sh−1,900→ 20,243 total
Sale
Natera, Inc.$NTRA
Common Stock
2025-11-20$220.14/sh−1,184→ 24,843 total
Exercise/Conversion
Natera, Inc.$NTRA
Common Stock
2025-11-20$40.93/sh+600→ 18,959 total
Sale
Natera, Inc.$NTRA
Common Stock
2025-11-20$224.89/sh−1,884→ 18,359 total
Exercise/Conversion
Natera, Inc.$NTRA
Common Stock
2025-11-20$41.19/sh+7,068→ 26,027 total
Exercise/Conversion
Natera, Inc.$NTRA
Common Stock
2025-11-19$40.93/sh+5,112→ 23,471 total
Exercise/Conversion
Natera, Inc.$NTRA
Stock Option (right to buy)
2025-11-19−5,112→ 600 total
Sale
Natera, Inc.$NTRA
Common Stock
2025-11-19$213.47/sh−1,250→ 22,221 total
Sale
Natera, Inc.$NTRA
Common Stock
2025-11-19$216.07/sh−2,135→ 18,359 total
Sale
Natera, Inc.$NTRA
Common Stock
2025-11-19$214.79/sh−1,727→ 20,494 total
Award
Natera, Inc.$NTRA
Common Stock
2025-10-31+93→ 18,359 total
Award
Natera, Inc.$NTRA
Common Stock
2025-07-25+108→ 18,266 total
Award
Natera, Inc.$NTRA
Common Stock
2025-06-27+2,143→ 18,158 total
Award
Aardvark Therapeutics, Inc.$AARD
Stock Option (right to buy)
2025-06-11+30,508→ 30,508 total
Award
Nurix Therapeutics, Inc.$NRIX
Director Stock Option (right to buy)
2025-05-19+25,000→ 25,000 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-05-15+6,500→ 37,500 total
Award
Travere Therapeutics, Inc.$TVTX
Stock option (right to buy)
2025-05-15+19,500→ 19,500 total
Award
Natera, Inc.$NTRA
Common Stock
2025-04-25+116→ 16,015 total
Award
Nurix Therapeutics, Inc.$NRIX
Director Stock Option (right to buy)
2025-03-11+50,000→ 50,000 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-02-06$17.44/sh+10,000→ 41,000 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-02-06$22.00/sh−10,000→ 31,000 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Stock option (right to buy)
2025-02-06−10,000→ 0 total
Award
Natera, Inc.$NTRA
Common Stock
2025-01-31+92→ 15,899 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Stock option (right to buy)
2025-01-23−16,000→ 0 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-01-23$17.50/sh+16,000→ 47,000 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-01-23$20.00/sh−16,000→ 31,000 total
Award
Natera, Inc.$NTRA
Common Stock
2024-10-25+124→ 15,807 total
Award
Natera, Inc.$NTRA
Common Stock
2024-07-26+143→ 15,683 total
Award
Natera, Inc.$NTRA
Common Stock
2024-06-28+2,964→ 15,540 total
Award
Travere Therapeutics, Inc.$TVTX
Stock option (right to buy)
2024-05-08+19,500→ 19,500 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2024-05-08+6,500→ 31,000 total
Award
Natera, Inc.$NTRA
Common Stock
2024-04-26+169→ 12,576 total
Award
Natera, Inc.$NTRA
Common Stock
2024-01-26$63.79/sh+215→ 12,407 total
Award
Natera, Inc.$NTRA
Common Stock
2023-10-27$42.60/sh+322→ 12,192 total
Award
Natera, Inc.$NTRA
Common Stock
2023-07-28$48.48/sh+264→ 11,870 total
Award
Natera, Inc.$NTRA
Stock Option (right to buy)
2023-06-30+4,255→ 4,255 total
Award
Natera, Inc.$NTRA
Common Stock
2023-06-30+2,750→ 11,606 total
Exercise/Conversion
Natera, Inc.$NTRA
Restricted Stock Unit
2023-05-25−3,534→ 0 total
Exercise/Conversion
Natera, Inc.$NTRA
Common Stock
2023-05-25+3,534→ 8,856 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2023-05-17+4,500→ 24,500 total
Award
Travere Therapeutics, Inc.$TVTX
Stock option (right to buy)
2023-05-17+13,500→ 13,500 total
Award
Natera, Inc.$NTRA
Common Stock
2023-04-14$54.73/sh+228→ 5,322 total
Award
Natera, Inc.$NTRA
Common Stock
2023-01-13$40.01/sh+312→ 5,094 total
Award
Natera, Inc.$NTRA
Common Stock
2022-10-14$45.42/sh+275→ 4,782 total
Award
Natera, Inc.$NTRA
Common Stock
2022-07-08+344→ 4,507 total
Award
Natera, Inc.$NTRA
Restricted Stock Unit
2022-07-08$36.31/sh+344→ 344 total

Companies

Recent Filings

Address

C/O TRAVERE THERAPEUTICS, INC. 3611 VALLEY CENTRE DR., SUITE 300

SAN DIEGO, CA, 92130

View on SEC.gov